TLC BioPharmaceuticals

Taiwan Liposome Company (TLC) is a specialty biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products based on its proprietary drug delivery technologies for improving the treatment of cancers, peripheral arterial disease (PAD), age-related macular degeneration (AMD) and infectious diseases.